Analysts have raised their targets and issued some very interesting calls lately on which stocks they think will be major players in the coming year, from Apple to Walmart.
Aprea Therapeutics stock was absolutely crushed to start out the week after the company announced results from its late-stage trial evaluating the safety and efficacy of its treatment for myelodysplastic syndromes.
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
Altimmune shares dropped on Thursday after the company announced that it had received an update from the FDA regarding its COVID-19 vaccine candidate.
Tuesday's midday analyst calls included Peloton Interactive, Biogen, Square and Lockheed Martin.
Here are some of the biggest IPO losers this year, several of which came public before the pandemic hit.
Aurora Mobile entered the electric vehicles ring on Tuesday and saw its shares nearly double in the premarket.
Here are five of the biggest winners in the S&P 500 so far in 2020. Can they keep up the pace into 2021 as the markets continue to push higher?
Tesla, Marriott and Kinder Morgan are among the most overvalued stocks in the S&P 500 this year.
Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.
FedEx reported better than expected fiscal second-quarter results after the markets closed on Thursday. Although investors were not happy with results, analysts were fairly positive.
Robinhood has been a source of controversy on Wall Street for years now, and this is all coming to a head with the most recent charges from the SEC.
Jabil reported better than expected quarterly results before the markets opened on Thursday. What comes next?
24/7 Wall St. looks at some of the biggest dividend yields in the S&P 500 and why they may be worth buying into.
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
DraftKings announced Tuesday that it would be partnering with a global payments technology company to launch a first-of-its-kind retail gift card.
Most investors would think that the best stock in the index would have ties to COVID-19 in some fashion, but online marketplace Etsy has only obliquely benefited from the pandemic.
BioNTech was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.
Prevail Therapeutics shares absolutely exploded on Tuesday morning after it was announced that the company would be acquired by Eli Lilly.
Alexion Pharmaceutical shares shot up on Monday after it was announced over the weekend that the company would be acquired by AstraZeneca.
